Synthetic Generation of Hematological Data Over Federated Computing Frameworks: SCD Use Case (SYNTHEMA (SCD))
Synthetic Generation of Hematological Data Over Federated Computing Frameworks (SYNTHEMA): SCD Use Case
Sponsor: Assistance Publique - Hôpitaux de Paris
A observational or N/A phase clinical study on Sickle Cell Disease, this trial is ongoing. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 3 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting
-
Apr 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
Feb 2025 — Apr 2025 [monthly]
Active Not Recruiting
First recorded
Nov 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Charite University, Berlin, Germany
- Datawizard SRL
- GLSMED Learning Health S.A.
- Hospital Universitari Vall d'Hebron Research Institute
- Humanitas Mirasole SpA
- Intrasoft
- UMC Utrecht
- Universidad Politecnica de Madrid
- Universita degli Studi di Padova
- University of Southampton
- Vicomtech
For direct contact, visit the study record on ClinicalTrials.gov .